Full Text
PCN15 COST-EFFECTIVENESS OF NEW TARGETED THERAPY SUNITINIB MALATE AS SECOND LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA IN ARGENTINA

Abstract

Authors

EC Aiello N Muszbek E Richardet A Lingua C Charbonneau E Remák

Back to Volume 10, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×